[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368980-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368980-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","imaging-protoporphyrin-ix-photoproduct-accumulation-as-a-dosimetry-reporter-for-monitoring-photodynamic-therapy-of-oral-cancer","Imaging protoporphyrin IX photoproduct accumulation as a dosimetry reporter for monitoring photodynamic therapy of oral cancer","","Photodynamic therapy (PDT) for oral cancers and oral potentially malignant lesions may be improved by using the photosensitizer as a fluorescence contrast agent to guide treatment. Image-based dosimetry reporters can support real-time treatment monitoring, helping avoid under-treatment that can lead to incomplete response and recurrence. This work tests whether imaging protoporphyrin IX (PpIX) photoproduct (PP) accumulation provides implicit PDT dosimetry during 5-aminolevulinic acid (ALA)–induced PpIX sensitization.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/imaging-protoporphyrin-ix-photoproduct-accumulation-as-a-dosimetry-reporter-for-monitoring-photodynamic-therapy-of-oral-cancer/368980/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/imaging-protoporphyrin-ix-photoproduct-accumulation-as-a-dosimetry-reporter-for-monitoring-photodynamic-therapy-of-oral-cancer/368980.png","ImageObject",300,407,{"name":42,"@type":43},"nayy☆","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical problem does the study address in oral cancer PDT?","Question",{"text":63,"@type":64},"The study targets the need for reliable treatment monitoring to reduce uncertainty, specifically to avoid under-treatment that can lead to incomplete response and recurrence.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the proposed dosimetry concept tested in the paper?",{"text":68,"@type":64},"The paper investigates whether imaging protoporphyrin IX (PpIX) photoproduct (PP) accumulation can function as an implicit PDT dosimetry reporter during ALA-induced sensitization.",{"name":70,"@type":61,"acceptedAnswer":71},"How are PP imaging and PpIX photobleaching related in the reported results?",{"text":72,"@type":64},"The results describe that PP signal increases in a fluence-dependent manner alongside PpIX photobleaching and correlates with cytotoxic response in 3D cultures, and PP accumulation is also observed in OSCC xenografts.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368980,1790479117,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","RESEARCH PAPER  \nImaging protoporphyrin IX photoproduct accumulation as a dosimetry reporter for monitoring photodynamic therapy of oral cancer  \nChristian Liboy  ,a,b,† Shakir Khan  ,b,c,† Bofan Song,d Deshawn Vega,b  \nMohammad A. Saad  ,c Rongguang Liang  ,d Tayyaba Hasan  ,c,e  \nand Jonathan P. Cellib,c,*  \naBoston College, Boston, Massachusetts, United States  \nbUniversity of Massachusetts Boston, Boston, Massachusetts, United States cMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston,  \nMassachusetts, United States  \ndUniversity of Arizona, Wyant College of Optical Sciences, Tucson, Arizona, United States eHarvard University and Massachusetts Institute of Technology, Division of Health Sciences and Technology,  \nCambridge, Massachusetts, United States  \nABSTRACT. Significance: Photodynamic therapy (PDT) for the treatment of oral cancersand oral potentially malignant lesions can be enhanced by the capability of the photosensitizer to serve as a fluorescence contrast agent for treatment guidance. The development of image-based dosimetry reporters can inform treatment progress in real time to avoid under-treatment, leading to incomplete response and recurrence.  \nAim: We investigate the hypothesis that imaging of protoporphyrin IX (PpIX) photoproduct (PP) accumulation may be leveraged as an implicit PDT dosimetry reporter for PDT using 5-aminolevulinic acid (ALA)-induced PpIX photosensitization.  \nApproach: In initial spectroscopy studies, we investigate dose-dependent changes in absorption and fluorescence spectra of PpIX corresponding to PP accumulation during red light (635 nm) delivery. We use spectral analysis to select fluorescence excitation and spectral filtering components for PP imaging during treatment. We evaluate the capability for imaging PP accumulation concomitant with PpIX photobleaching in tissue phantoms, 3D oral squamous cell carcinoma (OSCC) models, and in murine xenografts.  \nResults: Spectroscopy shows fluence-dependent changes in PpIX optical properties, and that excitation of photobleached PpIX with 450 nm light produces fluorescence emission associated with PpIX PPs. An existing handheld intraoral probe is shown to be capable of imaging dose-dependent PP accumulation with the addition of a spectral filter to isolate fluorescence emission longer than 650 nm. PP signal increases concomitant with PpIX photobleaching in a fluence-dependent manner and correlates with the extent of cytotoxic response in 3D cultures. PP accumulation is also observed to occur concomitantly with photobleaching in OSCC subcutaneous xenografts.  \nConclusions: Overall, the results show that imaging of PP accumulation is feasible by adapting traditional photodiagnosis optical components and may serve as adosimetry reporter for ALA-PDT, which is complementary to the measurement of PpIX photobleaching.  \n© The Authors. Published by SPIE under a Creative Commons Attribution 4.0 International License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.30.S3.S34114]  \n*Address all correspondence to Jonathan P. Celli, [Jonathan.Celli@umb.edu](Jonathan.Celli@umb.edu)[ ](Jonathan.Celli@umb.edu)†These authors contributed equally to this work.  \nJournal of Biomedical Optics S34114-1 Vol. 30(S3)  \nLiboy et al.: Imaging protoporphyrin IX photoproduct accumulation as a dosimetry. . .  \nKeywords: photodynamic therapy; 5-aminolevulinic acid (ALA); protoporphyrin IX photoproducts; photobleaching; oral cancer; photodynamic therapy dosimetry  \nPaper 250277SSR received Sep. 3, 2025; revised Nov. 14, 2025; accepted Nov. 17, 2025; published Dec.  \n9, 2025 .  \n1 Introduction  \nIn this study, we investigate a treatment monitoring approach for photodynamic therapy (PDT) of oral lesions based on fluorescence imaging of the accumulation of protoporphyrin IX (PpIX) photoproduct (PP) during light delivery. T","cbCaikIXzSkWzng9","https://ap.wps.com/l/cbCaikIXzSkWzng9","pdf",10741644,14,"English","# Introduction\n## Photodynamic therapy background and clinical need\n## Study motivation for oral lesion treatment monitoring\n# Aim and hypothesis\n## Imaging PpIX photoproduct accumulation as dosimetry","[{\"question\":\"What clinical problem does the study address in oral cancer PDT?\",\"answer\":\"The study targets the need for reliable treatment monitoring to reduce uncertainty, specifically to avoid under-treatment that can lead to incomplete response and recurrence.\"},{\"question\":\"What is the proposed dosimetry concept tested in the paper?\",\"answer\":\"The paper investigates whether imaging protoporphyrin IX (PpIX) photoproduct (PP) accumulation can function as an implicit PDT dosimetry reporter during ALA-induced sensitization.\"},{\"question\":\"How are PP imaging and PpIX photobleaching related in the reported results?\",\"answer\":\"The results describe that PP signal increases in a fluence-dependent manner alongside PpIX photobleaching and correlates with cytotoxic response in 3D cultures, and PP accumulation is also observed in OSCC xenografts.\"}]","Imaging protoporphyrin IX photoproduct accumulation as a dosimetry reporter for monitoring photodynamic therapy of oral cancer | PDF",1790180006,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00c7c30218ab8bba6e7cdfc8a844dd1.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/858f7255fa0863244ba75940b484306a.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c02be91dae06b3ea09fb1499f60a273.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/503af37c2e95c0a0f164b606bc17d9ee.webp",980,1268]